Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLeg swelling is not listed as a common side effect of Mounjaro in its UK prescribing information. Tirzepatide's recognised side-effect profile is led by gastrointestinal symptoms rather than fluid retention in the legs. That said, a small number of people taking any new medicine do notice unexpected changes, so it is worth understanding what the evidence actually says — and when swollen legs deserve prompt medical attention regardless of what you are taking. Mounjaro is a prescription-only medicine; a consultation with a GPhC-registered prescriber is the right starting point for any questions about suitability.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When a medicine goes through clinical trials and regulatory review, every reported adverse event is catalogued and assigned a frequency. For tirzepatide (Mounjaro), the UK Summary of Product Characteristics (the definitive clinical reference, published on the eMC) lists the following as very common or common effects: nausea, diarrhoea, vomiting, constipation, reduced appetite, indigestion, stomach pain, fatigue, injection-site reactions and dizziness. Peripheral oedema (swelling in the lower limbs caused by fluid pooling) does not appear in this common-effects list. So the short answer to the question is: no, Mounjaro is not recognised as a cause of leg swelling based on the trial programme that supported its approval.
That programme, as our tirzepatide overview explains, included thousands of adults across the SURMOUNT studies — SURMOUNT-1 alone randomised more than 2,500 participants over 72 weeks. Peripheral oedema was not a signal that emerged at meaningful frequency in that data.
You can check the NHS medicines page for tirzepatide for a plain-English summary of the side effects to expect; if you want the complete clinical picture, the Mounjaro SmPC on the eMC contains the full adverse-event breakdown with frequencies.
Here is a misconception worth addressing gently: it is tempting to attribute any new physical symptom to the most recent medicine you started. In practice, leg swelling has many causes that are entirely unrelated to tirzepatide, venous insufficiency, prolonged sitting, changes in diet and sodium intake, heart or kidney conditions, and certain other medicines (antihistamines, some calcium-channel blockers, steroids) are all common culprits.
Some people starting Mounjaro change their routine considerably: they eat less, move differently, and may sit or lie down more during early weeks when nausea is highest. Reduced movement can contribute to mild ankle swelling. Others find that rapid weight change affects circulation patterns slightly as the body adjusts. None of these mechanisms involves tirzepatide acting directly on fluid regulation in the tissues.
If you are also wondering about other physical sensations in the legs, our page on Mounjaro and leg pain covers the evidence for aches and cramps, and the question of injecting Mounjaro in the thigh sometimes prompts local reactions that are worth distinguishing from systemic swelling.
Regardless of what medicine you are taking, some patterns of leg swelling should prompt a same-day call to your GP or, if severe, a visit to urgent care. Seek medical help if you notice sudden swelling in one leg (particularly with redness, warmth or tenderness, which can indicate a deep vein thrombosis), swelling that comes on quickly alongside breathlessness or chest pain, or pitting oedema that does not improve with rest and elevation. These presentations need investigation in their own right.
The MHRA Yellow Card scheme allows patients to report any unexpected side effect they experience while on a prescription medicine, including something like leg swelling that does not appear in the current SmPC. These reports contribute to ongoing safety monitoring; if you genuinely believe your swelling started with Mounjaro and has no other explanation, submitting a Yellow Card report is a responsible step alongside speaking to your prescriber.
Our frequently asked questions section covers a range of safety queries about Mounjaro treatment.
If you are already on treatment and develop new leg swelling, tell your prescriber before assuming it is or is not related to Mounjaro. A clinician can review your full medicines list, relevant history and the swelling's characteristics to work out the most likely cause and whether anything needs changing. This is especially relevant if you take medicines for blood pressure or heart conditions alongside tirzepatide, since interactions with those drugs, rather than tirzepatide itself, can affect fluid balance.
At nume, every repeat order goes through a fresh clinical review, a real prescriber reads your update, not software. If something has changed between orders, that review is the right moment to raise it. You can read more about how treatment is overseen on our Mounjaro treatment page, or explore the broader weight-loss treatment options we offer if you are still deciding which medicine is right for you. For anything that feels urgent, our aftercare team is available seven days a week.
Side effects that do not involve the legs but still come up regularly include gas and bloating, so if you are dealing with more than one new symptom it may be worth reviewing all of them with your prescriber at once. If you are based in South Yorkshire, our Mounjaro Sheffield page explains how local patients can access treatment and clinical support.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.